The Burden of Hepatitis B and C in Asia, 1990–2019: An Update Analysis From the Global Burden of Disease Study 2019

IF 6 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Liver International Pub Date : 2025-01-22 DOI:10.1111/liv.70004
Qi Chen, Shu Huang, Jieyu Peng, Ping Wang, Xiaomin Shi, Rui Luo, Huan Xu, Wei Zhang, Lei Shi, Yan Peng, Fangfang Yuan, Xiaowei Tang
{"title":"The Burden of Hepatitis B and C in Asia, 1990–2019: An Update Analysis From the Global Burden of Disease Study 2019","authors":"Qi Chen,&nbsp;Shu Huang,&nbsp;Jieyu Peng,&nbsp;Ping Wang,&nbsp;Xiaomin Shi,&nbsp;Rui Luo,&nbsp;Huan Xu,&nbsp;Wei Zhang,&nbsp;Lei Shi,&nbsp;Yan Peng,&nbsp;Fangfang Yuan,&nbsp;Xiaowei Tang","doi":"10.1111/liv.70004","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>This research was aimed to uncover the hepatitis B virus (HBV) and hepatitis C virus (HCV) related diseases burden in Asia over the past 3 decades, estimating from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Age-standardised rates, case numbers of prevalence, disability-adjusted life-years (DALYs), incidence and deaths with 95% uncertainty intervals (UI) for HBV/HCV-related diseases from 1990 to 2019 were derived from GBD 2019 database, with the estimated annual percentage changes (EAPCs) calculated. Our analysis also encompassed the association between the Sociodemographic Index (SDI) and the burden of HBV/HCV-related diseases, future disease burden predictions in six selected countries and various risk factors.</p>\n </section>\n \n <section>\n \n <h3> Result</h3>\n \n <p>A general downward trend in the age-standardised rates of death, disability-adjusted life years (DALYs), prevalence and incidence for both HBV and HCV-related diseases was observed in Asia during the past 30 years. Despite overall declining trends, some analysed diseases experienced an increase. Compared with females, the disease burden was greater in the male population and peaked in the age of 50–54 for both sexes. It is significant for the HBV-related and HCV-related diseases burden in Afghanistan, Cambodia, Mongolia and Pakistan. Drug use and smoking were prominent contributors to HCV and HBV-related diseases. There was a negative relationship between the burden of HCV and HBV-related diseases and SDI.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Although decreases were observed in Asia, the HBV- and HCV-associated diseases burden remained high, highlighting that imperative measures for prevention and treatment should be taken by governments in Asia.</p>\n </section>\n </div>","PeriodicalId":18101,"journal":{"name":"Liver International","volume":"45 2","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Liver International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/liv.70004","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

This research was aimed to uncover the hepatitis B virus (HBV) and hepatitis C virus (HCV) related diseases burden in Asia over the past 3 decades, estimating from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.

Methods

Age-standardised rates, case numbers of prevalence, disability-adjusted life-years (DALYs), incidence and deaths with 95% uncertainty intervals (UI) for HBV/HCV-related diseases from 1990 to 2019 were derived from GBD 2019 database, with the estimated annual percentage changes (EAPCs) calculated. Our analysis also encompassed the association between the Sociodemographic Index (SDI) and the burden of HBV/HCV-related diseases, future disease burden predictions in six selected countries and various risk factors.

Result

A general downward trend in the age-standardised rates of death, disability-adjusted life years (DALYs), prevalence and incidence for both HBV and HCV-related diseases was observed in Asia during the past 30 years. Despite overall declining trends, some analysed diseases experienced an increase. Compared with females, the disease burden was greater in the male population and peaked in the age of 50–54 for both sexes. It is significant for the HBV-related and HCV-related diseases burden in Afghanistan, Cambodia, Mongolia and Pakistan. Drug use and smoking were prominent contributors to HCV and HBV-related diseases. There was a negative relationship between the burden of HCV and HBV-related diseases and SDI.

Conclusion

Although decreases were observed in Asia, the HBV- and HCV-associated diseases burden remained high, highlighting that imperative measures for prevention and treatment should be taken by governments in Asia.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
1990-2019年亚洲乙型和丙型肝炎负担:来自2019年全球疾病负担研究的最新分析
目的:本研究旨在揭示过去30年亚洲乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)相关疾病负担,这是根据2019年全球疾病、伤害和风险因素负担研究(GBD)估算的。方法:从GBD 2019数据库中获取1990年至2019年HBV/ hcv相关疾病的年龄标准化率、患病率病例数、残疾调整生命年(DALYs)、95%不确定区间(UI)的发病率和死亡率,并计算估计的年百分比变化(EAPCs)。我们的分析还包括社会人口统计指数(SDI)与HBV/ hcv相关疾病负担、六个选定国家未来疾病负担预测和各种危险因素之间的关系。结果:在过去的30年里,亚洲的年龄标准化死亡率、伤残调整生命年(DALYs)、HBV和hcv相关疾病的患病率和发病率普遍呈下降趋势。尽管总体呈下降趋势,但一些经分析的疾病出现了增加。与女性相比,男性人群的疾病负担更大,男女均在50-54岁达到高峰。这对阿富汗、柬埔寨、蒙古和巴基斯坦的hbv相关和hcv相关疾病负担具有重要意义。吸毒和吸烟是导致HCV和hbv相关疾病的主要因素。HCV和hbv相关疾病的负担与SDI呈负相关。结论:尽管亚洲地区的HBV和hcv相关疾病负担有所下降,但仍然很高,这表明亚洲各国政府应采取必要的预防和治疗措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Liver International
Liver International 医学-胃肠肝病学
CiteScore
13.90
自引率
4.50%
发文量
348
审稿时长
2 months
期刊介绍: Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies. Providing an international forum for the publication of high-quality original research in hepatology, it is an essential resource for everyone working on normal and abnormal structure and function in the liver and its constituent cells, including clinicians and basic scientists involved in the multi-disciplinary field of hepatology. The journal welcomes articles from all fields of hepatology, which may be published as original articles, brief definitive reports, reviews, mini-reviews, images in hepatology and letters to the Editor.
期刊最新文献
Issue Information FGF21 Analogues in Patients With Metabolic Diseases: Systematic Review and Meta-Analysis of Randomised Controlled Trials Methylprednisolone-Induced Liver Injury: Insights From FAERS Analysis and Comparison With DILIN Findings Refining the Safety Perspective of Bulevirtide in Chronic Hepatitis Delta Management Acute and acute-on-chronic liver failure: Pathogenesis, management and perspectives
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1